NDC 0078-0897 – Triesence

Triamcinolone Acetonide 40 mg/mL · Injection, Suspension · Ophthalmic

Human Prescription Drug

Product NDC0078-0897

Product details

Brand name
Triesence
Generic name
triamcinolone acetonide
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
Injection, Suspension
Route
Ophthalmic
Marketing category
NDA · NDA022048
Marketed since
October 1, 2024
Listing expires
December 31, 2027
Pharmacologic class
Corticosteroid

Active ingredients

Uses, dosage, side effects and warnings for Triesence →

Package NDC codes (1)

Package NDCDescriptionSince
0078-0897-781 BLISTER PACK in 1 CARTON (0078-0897-78) / 1 VIAL, GLASS in 1 BLISTER PACK / 1 mL in 1 VIAL, GLASSOct 1, 2024

Other Triesence products